We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.
- Authors
Yeo, Winnie; Chan, Paul K S; Ho, Wing M; Zee, Benny; Lam, Kwok C; Lei, Kenny I K; Chan, Anthony T C; Mok, Tony S K; Lee, Jam J; Leung, Thomas W T; Zhong, Sheng; Johnson, Philip J
- Abstract
For cancer patients receiving cytotoxic chemotherapy, hepatitis B virus (HBV) reactivation is a well described complication resulting in varying degrees of liver damage. The objectives of this study were to assess the efficacy of the antiviral agent lamivudine in reducing the incidence of HBV reactivation and diminishing morbidity and mortality of cancer patients with chronic HBV infection during chemotherapy.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Vol 22, Issue 5, p927
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2004.05.161